BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1859509)

  • 1. [Plasma and urine kinetics of amitriptyline oxide and its metabolites. Comparison of intravenous infusion and oral administration in volunteers].
    Hutt V; Theodor R; Pabst G; Dilger C; Mosberg H; Fischer W; Jaeger H
    Arzneimittelforschung; 1991 Apr; 41(4):367-72. PubMed ID: 1859509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single oral dose pharmacokinetics of amitriptylinoxide and amitriptyline in humans.
    Kuss HJ; Jungkunz G; Johannes KJ
    Pharmacopsychiatry; 1985 Jul; 18(4):259-62. PubMed ID: 4023050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state plasma levels during antidepressant therapy with amitriptyline and amitriptylinoxide.
    Koch H
    Isr J Psychiatry Relat Sci; 1990; 27(1):48-56. PubMed ID: 2194992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative single-dose kinetics of amitriptyline and its N-oxide in a volunteer.
    Breyer-Pfaff U; Ewert M; Wiatr R
    Arzneimittelforschung; 1978; 28(10b):1916-20. PubMed ID: 582519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bioequivalence of a new amitriptyline tablet formulation in comparison with a reference preparation].
    Metzner JE; Buchberger D; Dilger C; Läuter J; Schmidt U
    Arzneimittelforschung; 1998 Nov; 48(11):1072-8. PubMed ID: 9850427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary metabolites of amitriptylinoxide and amitriptyline in single-dose experiments and during continuous therapy.
    Becher B; Fischer W; Taneri Z; Scholz E; Müller WE; Breyer-Pfaff U
    Psychopharmacology (Berl); 1992; 106(3):303-10. PubMed ID: 1570375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of amitriptylinoxide and its major metabolites amitriptyline and nortriptyline in plasma by high-performance liquid chromatography.
    Terlinden R; Borbe HO
    J Chromatogr; 1986 Oct; 382():372-6. PubMed ID: 3782407
    [No Abstract]   [Full Text] [Related]  

  • 10. The kinetics of amitriptyline following single oral dose administration to man.
    Garland WA; Min BH; Birkett DJ
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):475-84. PubMed ID: 734227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amitriptyline and amitriptylinoxide after intravenous or oral administration in humans.
    Filser JG; Kaumeier S; Brand T; Schanz H; Terlinden R; Müller WE
    Pharmacopsychiatry; 1988 Nov; 21(6):381-3. PubMed ID: 3244775
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous and oral amitriptyline and its active metabolite nortriptyline in Greyhound dogs.
    Norkus C; Rankin D; KuKanich B
    Vet Anaesth Analg; 2015 Nov; 42(6):580-9. PubMed ID: 25683584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microliter samples of plasma.
    Robinson JD; Risby D; Riley G; Aherne GW
    J Pharmacol Exp Ther; 1978 May; 205(2):499-502. PubMed ID: 641845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):326-32. PubMed ID: 3015809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pharmacokinetics of oral amitriptyline and its active metabolite nortriptyline in fed and fasted Greyhound dogs.
    Norkus C; Rankin D; KuKanich B
    J Vet Pharmacol Ther; 2015 Dec; 38(6):619-22. PubMed ID: 25989225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quaternary N-glucuronides of 10-hydroxylated amitriptyline metabolites in human urine.
    Breyer-Pfaff U; Becher B; Nusser E; Nill K; Baier-Weber B; Zaunbrecher D; Wachsmuth H; Prox A
    Xenobiotica; 1990 Jul; 20(7):727-38. PubMed ID: 2238706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special experiments on central nervous effects of amitriptylinoxide considering pharmacokinetic aspects.
    Wenzl H
    Arzneimittelforschung; 1978; 28(10b):1879-83. PubMed ID: 582515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmortem amitriptyline pharmacokinetics in pigs after oral and intravenous routes of administration.
    Hilberg T; Ripel A; Smith AJ; Slørdal L; Mørland J; Bjørneboe A
    J Forensic Sci; 1998 Mar; 43(2):380-7. PubMed ID: 9544547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.